US2010221684A1PendingUtilityA1

Implant for subcutaneous or intradermal injection

53
Assignee: AVENTIS PHARMACEUTICALSPriority: Jun 13, 1997Filed: May 10, 2010Published: Sep 2, 2010
Est. expiryJun 13, 2017(expired)· nominal 20-yr term from priority
A61K 8/042A61K 2800/91A61L 2400/06A61K 8/025A61P 17/00A61P 1/02A61K 2800/412A61L 27/58A61Q 19/08A61L 27/50A61K 8/85A61Q 19/00A61P 17/02A61F 2/0059A61L 27/18A61L 27/00
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention concerns an injection implant for filling up wrinkles, thin lines, skin cracks and scars, for reparative or plastic surgery, aesthetic dermatology, and for filling up gums in dental treatment. The invention concerns the use of biologically absorbable polymer microspheres or microparticles suspended in a gel. Said suspension is produced either ready-for-use or freeze-dried. The biological absorbability of the microspheres is controlled and enables the production of implants having well defined persistence and deliberately limited to 3 years.

Claims

exact text as granted — not AI-modified
1 . A method of performing reparative or esthetic dermatologic surgery which
 comprises subcutaneously or intradermally injecting into a subject a bioresorbable injectable   implant consisting essentially of bioresorbable microspheres or microparticles suspended in a gel, wherein said microspheres or microparticles consist of at least one polymer selected from the group consisting of lactic acid polymers, glycolic acid polymers, and   lactic acid-glycolic acid co-polymers.   
     
     
         2 . The method according to  claim 1  wherein said surgery is for filling wrinkles, fine lines, skin cracks or scars. 
     
     
         3 . The method according to  claim 1  wherein said surgery is for filling the gums for dentistry. 
     
     
         4 . The method according to  claim 1  wherein said implant consists essentially of materials of non-animal origin. 
     
     
         5 . The method according to  claim 1  wherein said microspheres or microparticles have a mean diameter greater than 5 μm and less than 150 μm. 
     
     
         6 . The method according to  claim 1  wherein said microspheres or microparticles have a mean diameter greater than 20 μm and less than 80 μm. 
     
     
         7 . The method according to  claim 1  wherein said microspheres or microparticles have a mean diameter greater than 20 μm and less than 40 μm. 
     
     
         8 . The method according to  claim 1  wherein said polylactic acid has a molecular mass of between 70,000 and 175,000 Daltons. 
     
     
         9 . The method according to  claim 1  wherein said polylactic acid has a molecular mass of between 120,000 and 170,000 Daltons. 
     
     
         10 . The method according to  claim 1  wherein said polylactic acid has an intrinsic viscosity of between 3 and 4 dl/g. 
     
     
         11 . The method according to  claim 1  wherein said polylactic acid has an intrinsic viscosity of between 3.35 and 3.65 dl/g. 
     
     
         12 . The method according to  claim 1  wherein said microspheres or microparticles are present in said gel at a concentration of from 50-300 g/l. 
     
     
         13 . The method according to  claim 1  wherein said microspheres or microparticles are present in said gel at a concentration of from 60-200 g/l. 
     
     
         14 . The method according to  claim 1  wherein said gel consists essentially of water, from about 0.1 to about 7.5% (wt/wt) of an injectable gelling agent, and a surfactant. 
     
     
         15 . The method according to  claim 1  wherein said gel consists essentially of water and 0.1 to 7.5% by weight carboxymethylcellulose (CMC) or hydroxypropylmethylcellulose. 
     
     
         16 . The method according to  claim 14  wherein said gelling agent is a cellulose derivative. 
     
     
         17 . The method according to  claim 16  wherein said cellulose derivative is selected from the group consisting of carboxymethylcellulose and hydroxypropylmethylcellulose. 
     
     
         18 . The method according to  claim 14  wherein wherein said gelling agent is synthetic hyaluronic acid. 
     
     
         19 . The method according to  claim 14  wherein wherein said surfactant is selected from the group consisting of polyoxyethylene sorbitan monooleate and pluronic acid. 
     
     
         20 . The method according to  claim 1  wherein said microparticles consist of a polymer selected from the group consisting of poly-L-lactic acid, poly-D-lactic acid, and mixtures thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.